IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.791
EU - Europa 6.320
AS - Asia 4.970
SA - Sud America 605
AF - Africa 556
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
Totale 26.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.138
SG - Singapore 2.681
CN - Cina 1.928
IE - Irlanda 1.926
UA - Ucraina 1.787
IT - Italia 1.047
CA - Canada 639
BR - Brasile 570
RU - Federazione Russa 532
CI - Costa d'Avorio 461
SE - Svezia 280
GR - Grecia 193
VN - Vietnam 165
DE - Germania 119
GB - Regno Unito 84
CH - Svizzera 60
FI - Finlandia 59
SN - Senegal 58
FR - Francia 54
AT - Austria 41
NL - Olanda 41
UZ - Uzbekistan 39
IN - India 34
BE - Belgio 26
PL - Polonia 21
HK - Hong Kong 19
NG - Nigeria 16
TR - Turchia 16
EU - Europa 15
IQ - Iraq 15
BD - Bangladesh 13
CZ - Repubblica Ceca 12
AR - Argentina 11
JP - Giappone 11
LB - Libano 9
MA - Marocco 9
BG - Bulgaria 8
EC - Ecuador 7
MX - Messico 7
PK - Pakistan 7
KE - Kenya 6
PH - Filippine 6
VE - Venezuela 5
AZ - Azerbaigian 4
CO - Colombia 4
RS - Serbia 4
ZA - Sudafrica 4
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
ES - Italia 3
GE - Georgia 3
JO - Giordania 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
BH - Bahrain 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 26.260
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.364
Santa Clara 2.009
Dublin 1.924
Singapore 1.488
Chandler 1.374
Boardman 927
Nanjing 638
Houston 619
Lawrence 539
Andover 534
Cambridge 532
Toronto 497
Abidjan 461
Chicago 412
Des Moines 376
Catania 372
Ashburn 367
San Mateo 229
Nanchang 227
Civitanova Marche 202
Wilmington 185
Hebei 176
Shenyang 158
Dong Ket 141
Athens 136
Ottawa 133
Jiaxing 115
Saint Petersburg 114
Tianjin 113
Changsha 89
Milan 67
Dakar 58
Washington 56
Moscow 51
Los Angeles 48
Beijing 46
Bremen 41
Seattle 41
São Paulo 41
Lappeenranta 40
Norwalk 39
Hangzhou 38
Kunming 33
Jinan 32
Ningbo 29
Rome 27
Brussels 26
Den Haag 24
Hanoi 24
Pune 24
Liberty Lake 23
Zhengzhou 23
Palermo 22
Rio de Janeiro 21
Council Bluffs 20
Belo Horizonte 19
Helsinki 19
Gravina di Catania 18
Hong Kong 17
Abuja 16
Edinburgh 16
Taizhou 16
Ann Arbor 15
Frankfurt Am Main 14
Guangzhou 14
Munich 13
Padova 13
Pozzo Di Gotto 13
Falls Church 12
Manduria 12
Shanghai 11
Aigaleo 10
Changchun 10
Redwood City 10
Guarulhos 9
Kiev 9
Lausanne 9
Acireale 7
Brasília 7
Curitiba 7
Lanzhou 7
Princeton 7
Recife 7
Tappahannock 7
Baghdad 6
Campinas 6
Fairfield 6
Istanbul 6
Ludwigshafen 6
Phoenix 6
Porto Alegre 6
Providence 6
Salvador 6
Springfield 6
St Petersburg 6
Tashkent 6
Bussero 5
Canicattini Bagni 5
Civitavecchia 5
Fortaleza 5
Totale 18.781
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 511
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 225
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 135
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 125
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 121
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 95
SYNTAX Score II predicts carotid disease in a multivessel coronary disease population 89
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 85
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 83
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 83
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 82
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 82
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 82
[Management of severe stenosis controversies and promises] 79
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 79
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 79
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 77
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 77
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 76
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 76
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 76
Clinical decision making in left main revascularization: the past, the present and the future 75
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 74
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 74
Clinical implication of different plaque distribution patterns in distal left main coronary artery 73
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 73
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 72
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 72
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 72
Diabetes mellitus: the scary killer haunting silently 71
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 71
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 71
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 71
Transcatheter aortic valve implantation in 2017: state of the art 71
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 71
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 70
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 70
Quality of life assessment after percutaneous aortic valve implantation 70
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 70
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 70
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. 70
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 70
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 70
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 70
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 69
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 69
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 69
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 69
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 69
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 69
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 68
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 68
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 68
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 68
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 68
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 67
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 67
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 67
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 67
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 67
Antithrombotic Therapy in Patients with Chronic Kidney Disease 66
Spontaneous coronary artery dissection 66
Tailoring duration of DAPT with risk scores 66
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 66
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 66
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 66
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 66
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 65
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 65
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 65
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 65
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 65
Risk stratification after ST-elevation myocardial infarction 65
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 65
Update on clinical evidence (Part II): a summary of the main post market studies 65
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 65
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 64
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 64
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 64
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 64
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 64
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 64
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 63
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 63
Reply: plaque rupture in stable coronary artery disease 63
Impact of race and gender on antithrombotic therapy 63
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 63
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 63
Contrast Transesophageal Echocardiography Using the AcuNav Ultrasound Catheter Through Mouth Way as a Guide to Percutaneous Closure of Patent Foramen Ovale 63
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 63
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 63
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 62
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 62
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 62
Guideline-driven versus non-guideline driven approach for left main coronary artery revascularization: the Appraise a customized strategy for left main revascularization (CUSTOMIZE) study 62
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations 62
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA) 62
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice 62
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST- EU Registry - Reply 61
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 61
Totale 7.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.747
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020428 0 0 0 0 0 0 0 0 0 0 284 144
2020/20213.233 12 230 496 8 828 113 499 6 266 24 523 228
2021/20223.790 498 583 11 51 622 12 562 99 334 5 83 930
2022/20235.220 549 67 40 351 678 993 9 818 1.446 34 172 63
2023/20242.402 127 496 111 192 100 372 50 105 17 79 475 278
2024/20257.186 96 1.255 608 326 2.010 677 153 362 717 977 5 0
Totale 27.024